With the approval of Wegovy for MASH, we provide a new treatment to people living with MASH that not only halts the disease activity but helps reverse the damage caused to the liver. As of today, Wegovy is available in the US for the treatment for MASH
Since 2020, Utah Poison Control Center (UPCC) has seen a 640% increase in calls about GLP-1 medicine and about 20% of these cases have required a medical evaluation at a health care facility
MC EXPLAINER Semaglutides patent expires today
Biosynergy is committed to delivering high-quality, innovative solutions to global pharmaceutical markets
What does GLP-1 do in my body
El glutatin ofrece una accin despigmentante progresiva, aumento de luminosidad, efecto antioxidante, mejora del envejecimiento cutneo y refuerzo de la barrera cutnea